{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:13Z","timestamp":1744172893959,"version":"3.40.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11908-006-0048-y","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:04:09Z","timestamp":1180094649000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Severe skin and soft tissue infections and associated critical illness"],"prefix":"10.1007","volume":"8","author":[{"given":"Donald C.","family":"Vinh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Embil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"48_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1017\/S095026880500484X","volume":"134","author":"Simonsen SM Ellis","year":"2006","unstructured":"Ellis Simonsen SM, van Orman ER, Hatch BE, et al.: Cellulitis incidence in a de.ned population. Epidemiol Infect 2006, 134:293\u2013299.","journal-title":"Epidemiol Infect"},{"key":"48_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1473-3099(05)70191-2","volume":"5","author":"DC Vinh","year":"2005","unstructured":"Vinh DC, Embil JM: Rapidly progressive soft tissue infections. Lancet Infect Dis 2005, 5:501\u2013513.","journal-title":"Lancet Infect Dis"},{"key":"48_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, et al.: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303\u20131310.","journal-title":"Crit Care Med"},{"key":"48_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0732-8893(02)00543-6","volume":"45","author":"RP Rennie","year":"2003","unstructured":"Rennie RP, Jones RN, Mutnick AH, et al.: Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis 2003, 45:287\u2013293.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"48_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0732-8893(02)00468-6","volume":"44","author":"HS Sader","year":"2002","unstructured":"Sader HS, Jones RN, Silva JB, et al.: Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns. Diagn Microbiol Infect Dis 2002, 44:281\u2013288.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"48_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0924-8579(03)00154-7","volume":"22","author":"ME Jones","year":"2003","unstructured":"Jones ME, Karlowsky JA, Draghi DC, et al.: Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 2003, 22:406\u2013419.","journal-title":"Int J Antimicrob Agents"},{"key":"48_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1097\/01.CCM.0000129973.13104.2D","volume":"32","author":"J Cohen","year":"2004","unstructured":"Cohen J, Cristofaro P, Carlet J, et al.: New method of classifying infections in critically ill patients. Crit Care Med 2004, 32:1510\u20131526.","journal-title":"Crit Care Med"},{"key":"48_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.med.51.1.271","volume":"51","author":"DL Stevens","year":"2000","unstructured":"Stevens DL: Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000, 51:271\u2013288. A seminal review of the pathophysiology, clinical manifestations, and treatment of invasive S. pyogenes disease.","journal-title":"Annu Rev Med"},{"key":"48_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1056\/NEJM199608223350803","volume":"335","author":"HD Davies","year":"1996","unstructured":"Davies HD, McGeer A, Schwartz B, et al.: Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996, 335:547\u2013554.","journal-title":"N Engl J Med"},{"key":"48_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00005792-200307000-00001","volume":"82","author":"DM Aronoff","year":"2003","unstructured":"Aronoff DM, Bloch KC: Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 2003, 82:225\u2013235.","journal-title":"Medicine (Baltimore)"},{"key":"48_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJM199601253340407","volume":"334","author":"AL Bisno","year":"1996","unstructured":"Bisno AL, Stevens DL: Streptococcal infections of skin and soft tissues. N Engl J Med 1996, 334:240\u2013245.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"48_CR12","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1086\/321862","volume":"33","author":"RL Nichols","year":"2001","unstructured":"Nichols RL, Florman S: Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect Dis 2001, 33(Suppl 2):S84\u201393.","journal-title":"Clin Infect Dis"},{"key":"48_CR13","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1086\/317525","volume":"32","author":"T Simonart","year":"2001","unstructured":"Simonart T, Simonart JM, Derdelinckx I, et al.: Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 2001, 32:E9\u201312.","journal-title":"Clin Infect Dis"},{"key":"48_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0002-9343(97)00160-5","volume":"103","author":"R Kaul","year":"1997","unstructured":"Kaul R, McGeer A, Low DE, et al.: Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997, 103:18\u201324.","journal-title":"Am J Med"},{"key":"48_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archinte.163.4.467","volume":"163","author":"MP Muller","year":"2003","unstructured":"Muller MP, Low DE, Green KA, et al.: Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003, 163:467\u2013472.","journal-title":"Arch Intern Med"},{"key":"48_CR16","unstructured":"Centers for Disease Control and Prevention: Case definitions for infectious conditions under public health surveillance: Streptococcal toxic shock syndrome. MMWR 1997,46:33\u201334."},{"key":"48_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/01.qco.0000216623.82950.11","volume":"19","author":"BJ Currie","year":"2006","unstructured":"Currie BJ: Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress. Curr Opin Infect Dis 2006, 19:132\u2013138.","journal-title":"Curr Opin Infect Dis"},{"key":"48_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0092-8674(04)00057-1","volume":"116","author":"H Herwald","year":"2004","unstructured":"Herwald H, Cramer H, Morgelin M, et al.: M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004, 116:367\u2013379.","journal-title":"Cell"},{"key":"48_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0966-842X(02)02461-7","volume":"10","author":"DJ Banks","year":"2002","unstructured":"Banks DJ, Beres SB, Musser JM: The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 2002, 10:515\u2013521.","journal-title":"Trends Microbiol"},{"key":"48_CR20","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1073\/pnas.0404163101","volume":"101","author":"SB Beres","year":"2004","unstructured":"Beres SB, Sylva GL, Sturdevant DE, et al.: Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci USA 2004, 101:11833\u201311838.","journal-title":"Proc Natl Acad Sci USA"},{"key":"48_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.1101245","volume":"305","author":"H Sun","year":"2004","unstructured":"Sun H, Ringdahl U, Homeister JW, et al.: Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004, 305:1283\u20131286. An elegantly designed study providing insight into the host-specificity of S. pyogenes, as well as providing a key insight into the pathophysiology of invasive disease.","journal-title":"Science"},{"key":"48_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tim.2005.05.006","volume":"13","author":"MJ Walker","year":"2005","unstructured":"Walker MJ, McArthur JD, McKay F, et al.: Is plasminogen deployed as a Streptococcus pyogenes virulence factor? Trends Microbiol 2005, 13:308\u2013313.","journal-title":"Trends Microbiol"},{"key":"48_CR23","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1371\/journal.pmed.0030053","volume":"3","author":"P Thulin","year":"2006","unstructured":"Thulin P, Johansson L, Low DE, et al.: Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006, 3:e53.","journal-title":"PLoS Med"},{"key":"48_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molmed.2005.02.001","volume":"11","author":"GS Chhatwal","year":"2005","unstructured":"Chhatwal GS, McMillan DJ: Uncovering the mysteries of invasive streptococcal diseases. Trends Mol Med 2005, 11:152\u2013155.","journal-title":"Trends Mol Med"},{"key":"48_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(04)15643-2","volume":"363","author":"C Hidalgo-Grass","year":"2004","unstructured":"Hidalgo-Grass C, Dan-Goor M, Maly A, et al.: Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. Lancet 2004, 363:696\u2013703.","journal-title":"Lancet"},{"key":"48_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nm800","volume":"8","author":"M Kotb","year":"2002","unstructured":"Kotb M, Norrby-Teglund A, McGeer A, et al.: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002, 8:1398\u20131404.","journal-title":"Nat Med"},{"key":"48_CR27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/AAC.42.5.1266","volume":"42","author":"DL Stevens","year":"1998","unstructured":"Stevens DL, Madaras-Kelly KJ, Richards DM: In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes. Antimicrob Agents Chemother 1998, 42:1266\u20131268.","journal-title":"Antimicrob Agents Chemother"},{"key":"48_CR28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","volume":"18","author":"J Zimbelman","year":"1999","unstructured":"Zimbelman J, Palmer A, Todd J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999, 18:1096\u20131100.","journal-title":"Pediatr Infect Dis J"},{"key":"48_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/01.SMJ.0000051060.95210.9A","volume":"96","author":"ZD Mulla","year":"2003","unstructured":"Mulla ZD, Leaverton PE, Wiersma ST: Invasive group A streptococcal infections in Florida. South Med J 2003, 96:968\u2013973.","journal-title":"South Med J"},{"key":"48_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/00006454-200212000-00015","volume":"21","author":"AF Freeman","year":"2002","unstructured":"Freeman AF, Shulman ST: Macrolide resistance in group A Streptococcus. Pediatr Infect Dis J 2002, 21:1158\u20131160.","journal-title":"Pediatr Infect Dis J"},{"key":"48_CR31","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/AAC.43.9.2144","volume":"43","author":"JC De Azavedo","year":"1999","unstructured":"De Azavedo JC, Yeung RH, Bast DJ, et al.: Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother 1999, 43:2144\u20132147.","journal-title":"Antimicrob Agents Chemother"},{"key":"48_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1086\/432473","volume":"41","author":"SS Richter","year":"2005","unstructured":"Richter SS, Heilmann KP, Beekmann SE, et al.: Macrolideresistant Streptococcus pyogenes in the United States, 2002\u20132003. Clin Infect Dis 2005, 41:599\u2013608.","journal-title":"Clin Infect Dis"},{"key":"48_CR33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/AAC.49.2.788-790.2005","volume":"49","author":"T Ikebe","year":"2005","unstructured":"Ikebe T, Hirasawa K, Suzuki R, et al.: Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. Antimicrob Agents Chemother 2005, 49:788\u2013790.","journal-title":"Antimicrob Agents Chemother"},{"key":"48_CR34","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1128\/AAC.48.7.2716-2718.2004","volume":"48","author":"Y Uh","year":"2004","unstructured":"Uh Y, Jang IH, Hwang GY, et al.: Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob Agents Chemother 2004, 48:2716\u20132718.","journal-title":"Antimicrob Agents Chemother"},{"key":"48_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sjolin J, et al.: Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebocontrolled trial. Clin Infect Dis 2003, 37:333\u2013340.","journal-title":"Clin Infect Dis"},{"key":"48_CR36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","volume":"28","author":"R Kaul","year":"1999","unstructured":"Kaul R, McGeer A, Norrby-Teglund A, et al.: Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999, 28:800\u2013807.","journal-title":"Clin Infect Dis"},{"key":"48_CR37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/00365540410020866","volume":"37","author":"A Norrby-Teglund","year":"2005","unstructured":"Norrby-Teglund A, Muller MP, Mcgeer A, et al.: Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 2005, 37:166\u2013172.","journal-title":"Scand J Infect Dis"},{"key":"48_CR38","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/clinids\/21.6.1469","volume":"21","author":"F Lamothe","year":"1995","unstructured":"Lamothe F, D\u2019Amico P, Ghosn P, et al.: Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review. Clin Infect Dis 1995, 21:1469\u20131470.","journal-title":"Clin Infect Dis"},{"key":"48_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1086\/431589","volume":"41","author":"N Daneman","year":"2005","unstructured":"Daneman N, McGeer A, Low DE, et al.: Hospital-acquired invasive group A streptococcal infections in Ontario, Canada, 1992\u20132000. Clin Infect Dis 2005, 41:334\u2013342.","journal-title":"Clin Infect Dis"},{"key":"48_CR40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1473-3099(05)70190-0","volume":"5","author":"A Smith","year":"2005","unstructured":"Smith A, Lamagni TL, Oliver I, et al.: Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?\n                           Lancet Infect Dis 2005, 5:494\u2013500.","journal-title":"Lancet Infect Dis"},{"key":"48_CR41","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1086\/502503","volume":"26","author":"AE Simor","year":"2005","unstructured":"Simor AE, Ofner-Agostini M, Paton S, et al.: Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients. Infect Control Hosp Epidemiol 2005, 26:838\u2013841.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"48_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ajic.2003.09.002","volume":"31","author":"NNIS System","year":"2003","unstructured":"NNIS System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003, 31:481\u2013498.","journal-title":"Am J Infect Control"},{"key":"48_CR43","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.4065\/80.9.1201","volume":"80","author":"TJ Kowalski","year":"2005","unstructured":"Kowalski TJ, Berbari EF, Osmon DR: Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 2005, 80:1201\u20131207. A concise review on community-acquired MRSA, including key distinctive features from hospital-acquired MRSA.","journal-title":"Mayo Clin Proc"},{"key":"48_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN, et al.: Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53\u201359.","journal-title":"Clin Infect Dis"},{"key":"48_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.inf.0000109288.06912.21","volume":"23","author":"MC Lee","year":"2004","unstructured":"Lee MC, Rios AM, Aten MF, et al.: Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004, 23:123\u2013127.","journal-title":"Pediatr Infect Dis J"},{"key":"48_CR46","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMoa042683","volume":"352","author":"LG Miller","year":"2005","unstructured":"Miller LG, Perdreau-Remington F, Rieg G, et al.: Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445\u20131453.","journal-title":"N Engl J Med"},{"key":"48_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s10096-005-1329-3","volume":"24","author":"AY Peleg","year":"2005","unstructured":"Peleg AY, Munckhof WJ, Kleinschmidt SL, et al.: Lifethreatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur J Clin Microbiol Infect Dis 2005, 24:384\u2013387.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"48_CR48","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJMoa044194","volume":"353","author":"PV Adem","year":"2005","unstructured":"Adem PV, Montgomery CP, Husain AN, et al.: Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005, 353:1245\u20131251.","journal-title":"N Engl J Med"},{"key":"48_CR49","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa043252","volume":"352","author":"SK Fridkin","year":"2005","unstructured":"Fridkin SK, Hageman JC, Morrison M, et al.: Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436\u20131444.","journal-title":"N Engl J Med"},{"key":"48_CR50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/01.qco.0000186850.54040.fc","volume":"18","author":"MW Ellis","year":"2005","unstructured":"Ellis MW, Lewis JS 2nd: Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2005, 18:496\u2013501.","journal-title":"Curr Opin Infect Dis"},{"key":"48_CR51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","volume":"117","author":"N Markowitz","year":"1992","unstructured":"Markowitz N, Quinn EL, Saravolatz LD: Trimethoprimsulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992, 117:390\u2013398.","journal-title":"Ann Intern Med"},{"key":"48_CR52","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/429628","volume":"40","author":"JJ Ruhe","year":"2005","unstructured":"Ruhe JJ, Monson T, Bradsher RW, et al.: Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005, 40:1429\u20131434.","journal-title":"Clin Infect Dis"},{"key":"48_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1086\/426894","volume":"40","author":"JS Lewis 2nd","year":"2005","unstructured":"Lewis JS 2nd, Jorgensen JH: Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005, 40:280\u2013285.","journal-title":"Clin Infect Dis"},{"key":"48_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jac\/48.2.315","volume":"48","author":"D Drinkovic","year":"2001","unstructured":"Drinkovic D, Fuller ER, Shore KP, et al.: Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrobial Chemother 2001, 48:315\u2013316.","journal-title":"J Antimicrobial Chemother"},{"key":"48_CR55","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/jac\/44.4.581","volume":"44","author":"S Panagea","year":"1999","unstructured":"Panagea S, Perry JD, Gould FK: Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?\n                           J Antimicrobial Chemother 1999, 44:581\u2013582.","journal-title":"J Antimicrobial Chemother"},{"key":"48_CR56","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/45.5.715","volume":"45","author":"GG Rao","year":"2000","unstructured":"Rao GG: Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrobial Chemother 2000, 45:715.","journal-title":"J Antimicrobial Chemother"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-006-0048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-006-0048-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-006-0048-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-006-0048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:22:57Z","timestamp":1744147377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-006-0048-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1007\/s11908-006-0048-y","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"type":"print","value":"1523-3847"},{"type":"electronic","value":"1534-3146"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}